Fundraising FoxCuriva
1 known investors
Find your way into Curiva
Sign up to see every warm intro you have to Curiva
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Curiva team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Curiva develops diaPatch, a non-invasive wearable diagnostic patch that samples interstitial fluid via microneedles and runs a molecular assay to support cervical cancer risk stratification and triage after an abnormal Pap smear. It targets cancer centers, hospitals, clinics, and physician offices to reduce reliance on invasive colposcopy and deliver same-visit results.
Investors · 1
Frequently asked questions
- What does Curiva do?
- Curiva develops diaPatch, a non-invasive wearable diagnostic patch that samples interstitial fluid via microneedles and runs a molecular assay to support cervical cancer risk stratification and triage after an abnormal Pap smear. It targets cancer centers, hospitals, clinics, and physician offices to reduce reliance on invasive colposcopy and deliver same-visit results.
- Who are Curiva's investors?
- Curiva's investors include Josephine Collective.